Prentað þann 25. des. 2024
789/2010
Reglugerð um (6.) breytingu á reglugerð nr. 233/2001 um ávana- og fíkniefni og önnur eftirlitsskyld efni.
1. gr.
Fylgiskjal I við reglugerðina skal vera sem hér segir:
Fylgiskjal I.
Skýringar:
B | Efni sem bönnuð eru á íslensku yfirráðasvæði, sbr. 2. gr. laga um ávana- og fíkniefni, nr. 65/1974 með síðari breytingum og 2. gr. þessarar reglugerðar. |
N I - IV | Efni listuð á fylgiskjölum I-IV með alþjóðasamningi um ávana- og fíkniefni 1961 með síðari breytingum (Single Convention on Narcotic Drugs of 1961, and the Protocol of 25 March 1972 amending the Single Convention on Narcotic Drugs of 1961). |
P I - IV | Efni listuð á fylgiskjölum I-IV með alþjóðasamningi um ávana- og fíkniefni 1971 með síðari breytingum (Convention on Psychotropic Substances 1971). |
Óflokkuð efni | Efni sem ýmist eru þekktar afleiður af efnum á listum INCB eða efni, sem valda fíkn eða eru ávanabindandi. |
Efni | Annað nafn | Alþjóða-samningar | Bannað | Undanþágur og athugasemdir |
(1-phenyl-1-piperidyl-(2)-methyl)acetat | x | |||
1,4-butandiol | x | |||
2C-B | 4-bromo-2,5-dimethoxyphenethylamine | P II | x | |
2C-E | 4-ethyl-2,5-dimethoxyphenethylamine | x | ||
2C-I | 4-jodo-2,5-dimethoxyphenethylamine | x | ||
2C-P | 2,5-dimethoxy-4-propylphenethylamine | x | ||
2C-T-2 | 2,5-dimethoxy-4-ethylthiophenethylamine | x | ||
2C-T-7 | 2,5-dimethoxy-4-(n)-propylthiophentylamine | x | ||
3-methylfentanyl | N I+IV | |||
3-methylthiofentanyl | N I+IV | |||
4-fluoroamphetamine | x | |||
4-methylaminorex | P I | x | ||
4-MTA | α-methyl-4-methylthiophenethylamine | P I | x | |
5-(1,1-dimethylhexyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol | CP47, 497-C6 | x | ||
5-(1,1-dimethylheptyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol | CP47, 497-C7 | x | ||
5-(1,1-dimethyloctyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol | CP47, 497-C8 | x | ||
5-(1,1-dimethylnonyl)-2-((1R,3S)-3-hydroxycyclohexyl)-phenol | CP47, 497-C9 | x | ||
Acetorphine | N I+IV | x | ||
Acetyl-α-methylfentanyl | N I+IV | |||
Acetyldihydrocodeine | N II+III | 1) | ||
Acetylmethadol | N I | |||
Alfentanil | N I | |||
Allobarbital | P IV | x | ||
Allylprodine | N I | |||
Alphacetylmethadol | N I | |||
Alphameprodine | N I | |||
Alphamethadol | N I | |||
alpha-metylfentanyl | N I+IV | |||
alpha-metylthiofentanyl | N I+IV | |||
Alphaprodine | N I | |||
Alprazolam | P IV | |||
Amfepramone | diethylpropion | P IV | ||
Amfetamine | amphetamine | P II | x | 4) |
Amineptine | P II | |||
Aminorex | P IV | |||
Amobarbital | P III | |||
Anileridine | N I | |||
Aprobarbital | ||||
Barbital | P IV | |||
Bentazepam | ||||
Benzethidine | N I | |||
Benzfetamine | benzphetamine | P IV | ||
Benzylmorphine | N I | |||
Betacetylmethadol | N I | |||
beta-hydroxy-3-methylfentanyl | N I+IV | |||
beta-hydroxyfentanyl | N I+IV | |||
Betameprodine | N I | |||
Betamethadol | N I | |||
Betaprodine | N I | |||
Bezitramide | N I | |||
Brallobarbital | ||||
Brolamfetamine | DOB | P I | x | |
Brom-STP | 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)propane | x | ||
Bromazepam | P IV | |||
Bromo-Dragonfly | brombenzo-difuranyl-isopropylamine | x | ||
Brotizolam | P IV | x | ||
Bufoteninum | 5-hydroxy-dimethyltryptamine | |||
Buprenorphine | P III | |||
Butalbital | P III | |||
Butobarbital | P IV | x | ||
Butylone | 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one | |||
BZP | 1-benzylpiperazine | x | ||
Camazepam | P IV | |||
Cannabis | Kannabis, Hass, Marihuana | N I+IV | x | |
Cannabis-harpix | Kannabis harpix | N I+IV | x | |
Carfentanyl | ||||
Carisoprodolum | ||||
Catha edulis | Kaht | x | ||
Cathine | (+)-norpseudoephedrine | P III | x | |
Cathinone | P I | x | ||
Chloralhydrate | x | |||
Chloralodol | x | |||
Chlordiazepoxide | P IV | |||
Chlorphenterminum | 1-(4-chlorophenyl)-2-methylpropan-2-amine | |||
Clobazam | P IV | |||
Clobenzorexum | ||||
Clomethiazole | 4) | |||
Clonazepam | P IV | |||
Clonitazene | N I | |||
Clorazepate | P IV | |||
Clotiazepam | P IV | |||
Cloxazolam | P IV | |||
Coca blöð | Folium coca | N I | ||
Cocaine | N I+III | x | ||
Codeine | N II+III | 1) | ||
Codoxime | N I | |||
Cyclobarbital | P III | |||
Dibenzylpiperazine | 1,4-dibenzylpiperazine, DBZP | |||
Delorazepam | P IV | |||
Desomorphine | N I+IV | x | ||
DET | 3-[2-(diethylamino)ethyl]indole | P I | x | |
Dexamfetamine | dexamphetamine | P II | x | |
Dextromoramide | N I | |||
Dextropropoxyphene | N II+III | 3) | ||
Diampromide | N I | |||
Diazepam | P IV | |||
Diethylthiambutene | N I | |||
Difenoxin | N I+III | |||
Dihydrocodeine | N II+III | 1) | ||
Dihydroetorphine | N I | x | ||
Dihydromorphine | N I | |||
Dimenoxadol | N I | |||
Dimepheptanol | N I | |||
Dimethylthiambutene | N I | |||
Dioxaphetyl butyrate | N I | |||
Diphenoxylate | N I+III | 2) | ||
Dipipanone | N I | |||
DMA | (+-)-2,5-dimethoxy-α-methylphenethylamine | P I | x | |
DMHP | 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol | P I | x | |
DMT | 3-[2-(dimethylamino)ethyl]indole | P I | x | |
DOC | 4-chloro-2,5-dimethoxyamphetamine | x | ||
DOET | (+-)-4-ethyl-2,5-dimethoxy-α-methylphenethylamine | P I | x | |
DOI | 4-iodo-2,5-dimethoxyamphetamine | x | ||
Dronabinol | δ-9-tetrahydrocannabinol og stereoafleiður | P II | x | |
Drotebanol | N I | |||
Ecgonine | ásamt estum og afbrigðum þeirra sem hægt er að breyta í ecgonin eða kókaín | N I | ||
Estazolam | P IV | |||
Ethchlorvynol | P IV | |||
Ethinamate | P IV | |||
Ethylloflazepate | P IV | |||
Ethylmethylthiambutene | N I | |||
Ethylmorphine | N II+III | 1) | ||
Eticyclidine | PCE | P I | x | |
Etilamfetamine | N-ethylamphetamine | P IV | x | |
Etonitazene | N I | |||
Etorphine | N I+IV | x | ||
Etoxeridine | N I | |||
Etryptamine | P I | x | ||
Fenazepam | ||||
Fencamfamin | P IV | |||
Fenetylline | P II | x | ||
Fenfluramine | 3-trifluoromethyl-N-ethylamphetamine | x | ||
Fenproporex | P IV | |||
Fentanyl | N I | |||
Fludiazepam | P IV | |||
Flunitrazepam | P III | |||
Flurazepam | P IV | |||
Furethidine | N I | |||
gamma-hydroxybutyric acid | GHB | P IV | x | 4) |
gamma-hydroxybutyrate | GBH | x | ||
Glutethimide | P III | |||
Halazepam | P IV | |||
Haloxazolam | P IV | |||
Heptabarbitalum | ||||
Heroin | diacetylmorphine | N I+IV | x | |
Hexapropymat | ||||
Hexobarbitalum | ||||
Hydrocodone | N I | |||
Hydromorphinol | N I | |||
Hydromorphone | N I | |||
Hydroxypethidine | N I | |||
Ibogaine | (-)-12-Methoxyibogamine | x | ||
Isomethadone | N I | |||
Ketamine | ||||
Ketazolam | P IV | |||
Ketobemidone | N I+IV | x | 4) | |
Lefetamine | SPA | P IV | x | |
Levamfetamine | levamphetamine | P II | x | |
Levomethamphetamine | P II | x | ||
Levomethorphan | N I | |||
Levomoramide | N I | |||
Levonantradol | x | |||
Levophenacylmorphan | N I | |||
Levorphanol | N I | |||
Loprazolam | P IV | |||
Lorazepam | P IV | |||
Lormetazepam | P IV | |||
Lysergide | LSD, LSD-25 | P I | x | |
Mazindol | P IV | x | ||
MBDB | N-methyl-1-(3,4-methylendioxyphenyl)-2-butanamine | x | ||
mCPP | 1-(3-chlorophenyl)-piperazine | x | ||
MDE (N-ethyl-MDA) | (+-)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine | P I | x | |
MDMA | (+-)-N,α-dimethyl-3,4- (methylenedioxy)phenethylamine | P I | x | |
MDPV | 1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-yl-pentan-1-one | x | ||
Mecloqualone | P II | x | ||
Medazepam | P IV | |||
Mefedrone | 4-methylmethcathinone | x | ||
Mefenorex | P IV | |||
Meprobamate | P IV | |||
Mescaline | P I | x | ||
Mesocarb | P IV | |||
Metazocine | N I | |||
Metharbitalum | ||||
Methadone | N I | |||
Methadone-intermediate | 4-cyano-2-dimethylamino-4,4-diphenylbutane | N I | ||
Methamfetamine | methamphetamine | P II | x | |
Methamfetamine racemate | methamphetamine racemate | P II | x | |
Methaqualone | P II | x | ||
Methedrone | 1-(4-methoxyphenyl)-2-(methylamino)propan-1-one | x | ||
Methcathinone | P I | x | ||
Methohexitalum | ||||
Methyldesorphine | N I | |||
Methyldihydromorphine | N I | |||
Methylphenidate | P II | x | 4) | |
Methylphenobarbital | P IV | |||
Methylpentynol | ||||
Methyprylon | P IV | |||
Metopon | N I | |||
Midazolam | P IV | |||
MMDA | 5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine | P I | x | |
Modafinil | ||||
Moramide-intermediate | 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid | N I | ||
Morpheridine | N I | |||
Morphine | N I | |||
Morphine methobromide | og önnur morfínúrefni með 5-gildu köfnunaefni | N I | ||
Morphine-N-oxide | N I | |||
MPPP | 1-methyl-4-phenyl-4-piperidinol propionate (ester) | N I+IV | ||
Myrophine | N I | |||
N-ethyl-MDA (MDE) | (+-)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine | P I | x | |
N-hydroxyamphetamine | x | |||
N-hydroxy-MDA | (+-)-N[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine | P I | x | |
Nabilone | ||||
Napthalene-1-yl-(1-pentylindol-3-yl)methanone | JWH-018, JWH-073 | x | ||
Nicocodine | N II+III | 1) | ||
Nicodicodine | N II+III | 1) | ||
Nicomorphine | N I | |||
Nimetazepam | P IV | |||
Nitrazepam | P IV | |||
Noracymethadol | N I | |||
Norcodeine | N II+III | 1) | ||
Nordazepam | P IV | |||
Norlevorphanol | N I | |||
Normethadone | N I | |||
Normorphine | N I | |||
Norpipanone | N I | |||
Opium | N I+III | |||
Oripavine | N 1 | |||
Oxazepam | P IV | |||
Oxazolam | P IV | |||
Oxycodone | N I | |||
Oxymorphone | N I | |||
Panaeolus cyanescens | x | |||
para-fluorofentanyl | N I+IV | |||
Parahexyl | P I | x | ||
PBA | 1-phenyl-2-butylamine | x | ||
Pemoline | P IV | x | 4) | |
Pentazocine | P III | |||
Pentobarbital | P III | |||
PEPAP | 1-phenethyl-4-phenyl-4-piperidinol acetate | N I+IV | ||
Pethidine | N I | |||
Pethidine intermediate, A | 4-cyano-1-methyl-4-phenylpiperidine | N I | ||
Pethidine intermediate, B | 4-phenylpiperidine-4-carboxylic acid ethyl ester | N I | ||
Pethidine intermediate, C | 1-methyl-4-phenylpiperidine-4-carboxylic acid | N I | ||
Phenadoxone | N I | |||
Phenampromide | N I | |||
Phenazocine | N I | |||
Phencyclidine | PCP | P II | x | |
Phendimetrazine | P IV | x | ||
Phenmetrazine | P II | x | ||
Phenobarbital | P IV | |||
Phenomorphan | N I | |||
Phenoperidine | N I | |||
Phentermine | P IV | |||
Pholcodine | N II+III | 1) | ||
Piminodine | N I | |||
Pinazepam | P IV | |||
Pipradrol | P IV | |||
Piritramide | N I | |||
PMA | p-methoxy-α-methylphenethylamine | P I | x | |
PMMA, 4-MMA | 4-methoxy-N-methylamphetamine | x | ||
Poppy straw (valmúastrá) | ásamt þykkni unnu úr valmúastrái | N I | ||
Prazepam | P IV | |||
Proheptazine | N I | |||
Properidine | N I | |||
Propiram | N II+III | |||
Propylhexedrine | ||||
Psilocine (Psilotsin) | P I | x | ||
Psilocybine | P I | x | ||
Pyrityldion | 3,3-diethyl-2,4-dioxotetrahyrdropyridin | |||
Pyrovalerone | P IV | |||
Racemethorphan | N I | |||
Racemoramide | N I | |||
Racemorphan | N I | |||
Remifentanil | N I | |||
Rolicyclidine | PHP, PCPY | P I | x | |
Secbutabarbital | P IV | |||
Secobarbital | P II | x | ||
STP (DOM) | 2,5-dimethoxy-α-,4-dimethylphenethylamine | P I | x | |
Sufentanil | N I | |||
Tapentadol | ||||
Temazepam | P IV | |||
Tenamfetamine | MDA | P I | x | |
Tenocyclidine | TCP | P I | x | |
Tetrahydrocannabinol | og öll isomer þess og afleiður | P I | x | |
Tetrazepam | P IV | |||
Thebacon | N I | |||
Thebaine | N I | |||
Thiofentanyl | N I+IV | |||
Tilidine | N I | |||
TMA | (+-)-3,4,5-trimethoxy-α-methylphenethylamine | P I | x | |
TMA-2 | 2,4,5-trimethoxy-α-methylphenethylamine | x | ||
TMA-6 | 2,4,6-trimethoxyamphetamine | x | ||
Tramadol | ||||
Trifluoromethylphenylpiperazine | 1-(3-(trifluoromethyl)phenyl)piperazine, TFMPP | |||
Triazolam | P IV | |||
Trimeperidine | N I | |||
Tybamate | ||||
Vinbarbital | ||||
Vinylbital | P IV | x | ||
Zipeprol | P II | x | ||
Zopiclone | ||||
Zolpidem | P IV |
Undanþágur og athugasemdir
- Innflutnings-/útflutningsleyfi þarf ekki fyrir lyf sem innihalda minna en 100 mg í hverjum afmældum skammti eða minna en 2,5% efnisins.
- Ekki þarf innflutnings-/útflutningsleyfi vegna taflna, sem innihalda allt að 2,5 mg dífenoxýlats, ef þær innhalda einnig minnst 25 mcg af atrópínsúlfati í hverri töflu.
- Ekki þarf innflutnings-/útflutningsleyfi sérstaklega vegna lyfja, sem innihalda minna en 135 mg dextróprópoxýfen í hverri afmældri einingu eða 2,5% efnisins í óskömmtuðu lyfjaformi. Lyfið má hins vegar ekki innihalda nein önnur ávana- og fíkniefni merkt P I - P IV í fylgiskjali I.
- Undanþegin eru: Efni sem veitt hefur verið undanþága fyrir skv. 3. mgr. 2. gr. laga um ávana- og fíkniefni nr. 65/1974 með síðari breytingum, lyf sem hafa markaðsleyfi Lyfjastofnunar skv. 1. mgr. 7. gr. lyfjalaga nr. 93/1994 með síðari breytingum, lyf sem heimiluð hafa verið skv. 7. mgr. 7. gr. sömu laga, og efni sem veitt hefur verið leyfi til að flytja inn eða út, framleiða og selja í heildsölu skv. 1. mgr. 6. gr. reglugerðar þessarar.
2. gr.
Reglugerð þessi, sem sett er með heimild í 12. gr. lyfjalaga nr. 93/1994, með síðari breytingum og 2., 3. og 4. gr. laga um ávana- og fíkniefni nr. 65/1974, með síðari breytingum, öðlast þegar gildi.
Heilbrigðisráðuneytinu, 4. október 2010.
Guðbjartur Hannesson.
Guðríður Þorsteinsdóttir.
Fyrirvari
Reglugerðir eru birtar í B-deild Stjórnartíðinda skv. 3. gr. laga um Stjórnartíðindi og Lögbirtingablað, nr. 15/2005, sbr. reglugerð um útgáfu Stjórnartíðinda nr. 958/2005.
Sé misræmi milli þess texta sem birtist hér í safninu og þess sem birtur er í útgáfu B-deildar Stjórnartíðinda skal sá síðarnefndi ráða.